Columbia Ventures

Absci is a drug and target discovery company that utilizes deep learning AI and synthetic biology to enhance the therapeutic potential of proteins. By employing its Integrated Drug Creation Platform, Absci identifies novel drug targets and discovers optimal biotherapeutic candidates while simultaneously generating the necessary cell lines for manufacturing. This innovative approach allows biotech and pharmaceutical partners to develop next-generation protein-based drugs, including Bionic Proteins that incorporate nonstandard amino acids and other unique drug designs that may be unattainable through traditional methods. Absci's mission focuses on advancing the development of improved medicines by effectively translating innovative ideas into viable drugs.

Streem is an award winning technology company that enhances real-time communication and collaboration by creating an intelligent camera. The platform delivers a combination of augmented reality (AR), computer vision, and machine learning. It equips the expert with the capability to remotely capture crucial information by using proprietary spatial mapping, OCR, and object & pose estimation technology.

Columbia Pulp is an agriculture Company turning waste straw into pulp for papermaking and lignin for petrochemical replacements. It uses an innovative and proprietary technology to produce sustainable products. Columbia Pulp’s objective is to make valuable products out of waste straw. Columbia Pulp was founded in 2015 and is headquartered in Dayton, Washington, United States.

Saladax Biomedical, Inc. is a precision medicine company based in Bethlehem, Pennsylvania, specializing in the development and commercialization of diagnostic blood tests designed to enhance personalized medicine. The company focuses on adherence testing for psychiatrists and chemotherapeutic drug monitoring for oncologists. Its product line, known as MyCare, includes tests such as MyCare Psychiatry, which helps determine the appropriate antipsychotic dosage for patients; MyCare Oncology, which optimizes chemotherapy exposure; and MyCare Neurology, for assessing the effects of neurological drugs. Specific tests include My5-FU, MyPaclitaxel, MyDocetaxel, and MyImatinib, which are used to manage treatment for various cancers and conditions. Saladax markets its products through distributors across the Asia Pacific, European Union, Middle East, and North Africa, as well as through direct sales in select regions. With over 15 years of experience, Saladax aims to provide convenient and cost-effective solutions for therapeutic drug monitoring, enabling physicians to tailor drug dosing to individual patient needs.

MediaXstream is a provider of high-quality transport and managed network services, specializing in the delivery of flawless digital and high-definition content. The company caters to television and film production companies, mobile carriers, and other clients who require reliable and high-quality program delivery. As traditional production and broadcasting needs continue to evolve, MediaXstream focuses on maintaining the integrity of content transport, ensuring that both standard and high-definition programming is delivered in its native format. The company addresses the challenges posed by legacy telecom providers, who are increasingly shifting their focus to commodity IP platforms, which can compromise the quality of video signals.